BNP PARIBAS FINANCIAL MARKETS - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$33,317,000
+418.1%
34,608
+540.4%
0.00%
Q1 2022$6,431,000
-84.5%
5,404
-57.6%
0.00%
Q4 2021$41,578,000
-13.1%
12,754
+19.2%
0.00%
Q3 2021$47,825,000
+308.3%
10,699
+397.9%
0.00%
Q2 2021$11,712,000
-74.6%
2,149
-65.1%
0.00%
Q1 2021$46,039,000
-53.2%
6,155
-32.1%
0.00%
Q4 2020$98,290,000
+9.3%
9,059
-11.0%
0.00%
Q3 2020$89,938,000
+170.0%
10,174
+225.6%
0.00%
Q2 2020$33,312,000
-47.4%
3,125
-70.8%
0.00%
Q1 2020$63,362,000
+128.5%
10,685
+166.3%
0.00%
Q4 2019$27,730,000
-40.5%
4,013
-10.6%
0.00%
Q3 2019$46,606,000
+79.6%
4,490
+60.2%
0.00%
Q2 2019$25,947,000
-46.0%
2,802
-46.7%
0.00%
Q1 2019$48,058,000
+455.0%
5,258
+623.2%
0.00%
Q3 2018$8,659,000
+16.7%
7270.0%0.00%
Q2 2018$7,423,000
-80.7%
727
-75.5%
0.00%
Q1 2018$38,460,000
+48.7%
2,963
+11.4%
0.00%
Q4 2017$25,872,000
+33.6%
2,659
+102.1%
0.00%
Q3 2017$19,372,000
-10.1%
1,316
-1.7%
0.00%
Q2 2017$21,545,000
+1252.5%
1,339
+1239.0%
0.00%
Q1 2017$1,593,000
+9.2%
100
-16.7%
0.00%
Q4 2016$1,459,000
-36.6%
120
-27.7%
0.00%
Q3 2016$2,302,0001660.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,726,603$15,228,00010.06%
Flagship Pioneering Inc. 3,204,437$29,673,0001.28%
Redmile Group, LLC 3,620,376$33,525,0000.95%
ARK Investment Management 3,791,756$35,112,0000.88%
Nikko Asset Management Americas, Inc. 2,987,763$27,667,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,268,946$11,750,0000.42%
683 Capital Management, LLC 429,775$3,980,0000.36%
EcoR1 Capital, LLC 248,480$2,301,0000.23%
ALGERT GLOBAL LLC 17,920$166,0000.06%
Baker Brothers Advisors 974,835$9,027,0000.06%
View complete list of SYROS PHARMACEUTICALS INC shareholders